Latest News
Featured
All News
Keep up to date with the world of TENVIE
Welcome to the launch of Tenvie Therapeutics! We are thrilled to announce the official launch of Tenvie with a commitment to transform the treatment of neurological diseases.Follow us on our journey, covered by Global Newswire, STAT, Endpoints News, Fierce Biotech, and the San Francisco Business Times
Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases Led by expert R&D leadership team with proven ability to develop therapies for CNS and peripheral diseases ARCH Venture Partners, F-Prime Capital, and Mubadala Capital lead $200 million investment to fuel acceleration of Tenvie into a multi-clinical asset company SOUTH SAN FRANCISCO, January […]